Christian Angermayer
About Christian Angermayer
Christian Angermayer invests in life sciences, fintech, AI, psychedelics and cryptocurrencies through his family office Apeiron Investment Group.
He made his first millions cofounding biotech firm Ribopharma with his college professors; he sold his stake when it merged with Alnylam in 2003.
His Malta-based Apeiron owns shares in several publicly traded firms and private companies in the U.S., Germany, Canada and Australia.
His holdings include psychedelics biopharma firm Atai Life Sciences and blockchain holding company Cryptology, alongside co-investor Mike Novogratz.
He owns an extensive art collection that includes ancient artifacts highlighting the role that psychedelics have played in human history.
Personal stats
Citizenship
GermanySource of wealth
InvestmentsResidence
London, United KingdomBirth date
04/26/78 (age 46)Self-made
self-madeChristian Angermayer’s fortune is worth
troy ounces of gold
median U.S. household
median U.S. income
U.S. credit card volume
GDP of the United States
United States debt
Net worth history
Annual ranking
Related people
Net worth over time
Real-time ranking
Financial assets
XETRA | Z29-DE
029 GroupNASDAQ | ATAI-US
ATAI Life SciencesNASDAQ | ATAI-US
ATAI Life SciencesNASDAQ | BNOX-US
BionomicsNASDAQ | BNOX-US
BionomicsXETRA | CORE-DE
Coreo AGXETRA | SRAG-DE
Cryptology Asset Group PLCXETRA | NB2-DE
Northern Data AGTSX VENTURE | RCK-CA
Rock Tech LithiumXETRA | SBX-DE
SynBiotic SEUS OTC | HLCO-US
The Healing CompanyBERLIN | 9AUA-DE
The New Meat Company AGImages © Forbes.com. All rights reserved.